Analyst Research

Report Title Price
Provider: Stock Traders Daily
Provider: Thomson Reuters Stock Report
Provider: New Constructs, LLC
Provider: MacroRisk Analytics/EconomicInvestor

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

ImmunoGen Inc gives FY 2015 guidance above analysts' estimates

Friday, 1 Aug 2014 06:30am EDT 

ImmunoGen Inc:Expects FY 2015 revenues to be between $100 mln and $105 mln.Expects FY 2015 net loss to be between $60 mln and $65 mln.FY 2015 revenue of $71 mln and net income of $(78) mln - Thomson Reuters I/B/E/S. 

Company Quote

0.16 +1.81%
4:00pm EDT